Key regions: Australia, Italy, France, South Korea, Brazil
The Vaccines market in Seychelles has been experiencing a steady growth in recent years.
Customer preferences: Seychelles has a high demand for vaccines due to its growing population and increasing awareness about the importance of immunization. The government has been actively promoting vaccination programs, especially for children, through various initiatives and campaigns. The majority of the population prefers to get vaccinated through public health programs, which are free of charge and easily accessible.
Trends in the market: The Seychelles vaccine market has seen an increase in demand for vaccines against infectious diseases such as measles, mumps, rubella, and polio. The market has also seen a rise in demand for vaccines against non-infectious diseases such as cancer and allergies. This trend is mainly due to the increasing prevalence of these diseases in the country. The market has also seen a shift towards the use of combination vaccines, which provide protection against multiple diseases in a single shot. This trend is driven by the convenience and cost-effectiveness of combination vaccines.
Local special circumstances: Seychelles is a small island nation with a limited healthcare infrastructure. The government has been investing heavily in improving the healthcare system, including the vaccine supply chain. The country has a high vaccination coverage rate, which is a result of the government's efforts to provide free and easily accessible vaccines to the population. The government has also been working closely with international organizations to ensure the availability of vaccines in the country.
Underlying macroeconomic factors: Seychelles has a stable economy with a high GDP per capita. The country's healthcare expenditure is relatively high compared to other African countries. This has enabled the government to invest in the healthcare system, including the vaccine supply chain. The country's tourism industry is also a significant contributor to the economy. The government has been promoting Seychelles as a safe and healthy tourist destination, which has led to an increase in demand for vaccines among tourists.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
